NCT Number: NCT00392184
Partial Breast Irradiation With Multi-Catheter Brachytherapy for pT1-2pN0 Breast Cancer After Breast Conserving Surgery
The purpose of this study is to determine whether accelerated partial breast irradiation (APBI) with multi-catheter brachytherapy is safe and effective.
Looking for future studies?
Notify MeKey information
Conditions
Age range
35 year–80 year
Sex eligibility
Female
Study type
Interventional
Phase
Phase 2
Primary location
Hospital Barmherzige Schwestern Linz, Linz, Austria
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- pT1/2 (≤ 3 cm)
- pN0 or pN1 mi
- M0 and no contralateral BC
- Clear margins (≥ 2 mm)
- Age ≥ 35 years
- ER and/or PR positive
Exclusion criteria
- Multifocality or Multicentricity
- EIC
- Lymphovascular invasion
- Poorly differentiated tumors
- Diffuse microcalcifications
Treatment and study plan
Interested in participating?
Looking for future studies?
Notify MeSponsors and collaborators
Lead sponsor
University of Erlangen-Nürnberg Medical School
Other
Registry information
Important dates
- Study start
- 2000
- Primary completion
- 2009
- Study completion
- 2010
- First posted
- Oct 25, 2006
- Registry last updated
- Jun 1, 2015
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
HIIT Following Breast Cancer Chemotherapy
NCT05913713
Breast Cancer, Breast Diseases
Gainesville, Florida, United States
View Trial DetailsStudy of Neoadjuvant Olaparib Monotherapy and Olaparib and Durvalumab Combination in HER2 Negative BRCAm Breast Cancer
NCT05498155
Breast Cancer, Breast Diseases
Loveland, Colorado, United States
View Trial DetailsBreast Cancer Screening Uptake: a Randomized Controlled Trial Assessing the Effect of a Decisional Aid
NCT05607849
Breast Cancer, Breast Diseases
Nantes, France
View Trial DetailsCDK and Body Composition Study
NCT03697577
Breast Cancer, Breast Diseases
The Bronx, New York, United States
View Trial Details